$289.68 Million in Sales Expected for Ceridian HCM Holding Inc. (NYSE:CDAY) This Quarter

Wall Street analysts forecast that Ceridian HCM Holding Inc. (NYSE:CDAYGet Rating) will announce sales of $289.68 million for the current quarter, Zacks reports. Six analysts have provided estimates for Ceridian HCM’s earnings, with the highest sales estimate coming in at $290.90 million and the lowest estimate coming in at $288.80 million. Ceridian HCM posted sales of $234.50 million in the same quarter last year, which suggests a positive year-over-year growth rate of 23.5%. The company is expected to report its next quarterly earnings results after the market closes on Monday, January 1st.

According to Zacks, analysts expect that Ceridian HCM will report full-year sales of $1.21 billion for the current financial year, with estimates ranging from $1.20 billion to $1.21 billion. For the next year, analysts forecast that the firm will post sales of $1.41 billion, with estimates ranging from $1.38 billion to $1.44 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that cover Ceridian HCM.

Ceridian HCM (NYSE:CDAYGet Rating) last issued its earnings results on Wednesday, February 9th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.02). The firm had revenue of $282.10 million during the quarter, compared to analysts’ expectations of $274.98 million. Ceridian HCM had a negative return on equity of 2.73% and a negative net margin of 7.36%. During the same period last year, the firm posted ($0.02) earnings per share.

Several brokerages have issued reports on CDAY. Piper Sandler decreased their target price on shares of Ceridian HCM from $105.00 to $85.00 and set a “neutral” rating for the company in a report on Thursday, February 10th. Barclays decreased their target price on shares of Ceridian HCM from $83.00 to $60.00 and set an “underweight” rating for the company in a report on Tuesday, April 19th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Ceridian HCM from $110.00 to $105.00 and set a “buy” rating for the company in a report on Thursday, February 10th. Mizuho decreased their price objective on shares of Ceridian HCM from $140.00 to $100.00 and set a “buy” rating for the company in a report on Friday, January 28th. Finally, Wolfe Research cut shares of Ceridian HCM from a “peer perform” rating to an “underperform” rating in a report on Friday, February 11th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, Ceridian HCM has a consensus rating of “Hold” and an average target price of $96.45.

Shares of Ceridian HCM stock opened at $56.72 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 1.11. The stock has a market capitalization of $8.62 billion, a PE ratio of -113.44 and a beta of 1.47. Ceridian HCM has a 52-week low of $56.70 and a 52-week high of $130.37. The company has a 50-day simple moving average of $65.93 and a two-hundred day simple moving average of $90.29.

In other news, insider Jeffrey Scott Jacobs sold 784 shares of the company’s stock in a transaction on Wednesday, March 9th. The stock was sold at an average price of $62.49, for a total value of $48,992.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Christopher R. Armstrong sold 3,891 shares of the company’s stock in a transaction on Wednesday, February 9th. The stock was sold at an average price of $79.48, for a total value of $309,256.68. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 13,353 shares of company stock valued at $900,537. Company insiders own 3.90% of the company’s stock.

Several large investors have recently bought and sold shares of the company. Metropolitan Life Insurance Co NY boosted its holdings in Ceridian HCM by 35.4% in the 1st quarter. Metropolitan Life Insurance Co NY now owns 3,655 shares of the company’s stock worth $187,000 after buying an additional 955 shares during the period. First Trust Advisors LP bought a new position in Ceridian HCM in the 1st quarter worth $6,042,000. Morgan Stanley boosted its holdings in Ceridian HCM by 3.7% in the 2nd quarter. Morgan Stanley now owns 532,360 shares of the company’s stock worth $51,065,000 after buying an additional 18,865 shares during the period. Commonwealth Equity Services LLC bought a new position in Ceridian HCM in the 3rd quarter worth $343,000. Finally, Hartford Investment Management Co. bought a new position in Ceridian HCM in the 3rd quarter worth $1,416,000.

Ceridian HCM Company Profile (Get Rating)

Ceridian HCM Holding Inc, together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market.

Read More

Get a free copy of the Zacks research report on Ceridian HCM (CDAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Ceridian HCM (NYSE:CDAY)

Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.